Psychemedics Revenue 2010-2024 | PMD

Psychemedics revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Psychemedics Annual Revenue
(Millions of US $)
2023 $22
2022 $25
2021 $25
2020 $21
2019 $38
2018 $43
2017 $40
2016 $39
2015 $27
2014 $29
2013 $27
2012 $25
2011 $24
2010 $20
2009 $17
Psychemedics Quarterly Revenue
(Millions of US $)
2024-03-31 $5
2023-12-31 $5
2023-09-30 $6
2023-06-30 $6
2023-03-31 $6
2022-12-31 $6
2022-09-30 $7
2022-06-30 $7
2022-03-31 $7
2021-12-31 $6
2021-09-30 $7
2021-06-30 $6
2021-03-31 $6
2020-12-31 $5
2020-09-30 $5
2020-06-30 $3
2020-03-31 $8
2019-12-31 $9
2019-09-30 $10
2019-06-30 $9
2019-03-31 $10
2018-12-31 $10
2018-09-30 $11
2018-06-30 $11
2018-03-31 $11
2017-12-31 $10
2017-09-30 $10
2017-06-30 $10
2017-03-31 $10
2016-12-31 $11
2016-09-30 $12
2016-06-30 $10
2016-03-31 $7
2015-12-31 $6
2015-09-30 $7
2015-06-30 $7
2015-03-31 $7
2014-12-31 $7
2014-09-30 $8
2014-06-30 $8
2014-03-31 $7
2013-12-31 $6
2013-09-30 $7
2013-06-30 $7
2013-03-31 $6
2012-12-31 $6
2012-09-30 $6
2012-06-30 $7
2012-03-31 $6
2011-12-31 $6
2011-09-30 $6
2011-06-30 $6
2011-03-31 $6
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $5
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.013B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.391B 11.73
Quest Diagnostics (DGX) United States $16.058B 16.47
DaVita (DVA) United States $12.497B 15.52
Encompass Health (EHC) United States $9.126B 23.36
Chemed (CHE) United States $8.190B 25.03
Elanco Animal Health (ELAN) United States $6.335B 16.44
Option Care Health (OPCH) United States $5.388B 20.40
RadNet (RDNT) United States $4.578B 95.34
Amedisys (AMED) United States $3.194B 22.89
Astrana Health (ASTH) United States $2.939B 39.76
Addus HomeCare (ADUS) United States $2.192B 28.36
LifeStance Health (LFST) United States $2.118B 0.00
U.S Physical Therapy (USPH) United States $1.462B 39.11
Pennant (PNTG) United States $0.878B 46.37
Aveanna Healthcare Holdings (AVAH) United States $0.818B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00